tradingkey.logo

Hims & Hers falls after Novo Nordisk sues co for patent infringement

ReutersFeb 10, 2026 11:30 AM

Shares of telehealth company Hims & Hers Health HIMS.N fall 3% to $18.74 premarket

Danish drugmaker Novo Nordisk NOVOb.CO on Monday sued HIMS over patent infringement of semaglutide, the active ingredient in its blockbuster weight-loss pill Wegovy

HIMS also withdraws its $49 compounded version of semaglutide after scrutiny from the U.S. health regulator

HIMS stock has fallen for 7 straight days

As of last close, HIMS shares are down 40.5% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI